Market closed

Vera Therapeutics/$VERA

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Vera Therapeutics

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Ticker

$VERA
Trading on

Industry

Biotechnology

Employees

82
Website

VERA Metrics

BasicAdvanced
$2.9B
Market cap
-
P/E ratio
-$2.62
EPS
1.02
Beta
-
Dividend rate
$2.9B
1.02
$50.78
$12.28
942K
13.759
13.426
18.349
18.996
-21.33%
-33.37%
-65.11%
8.71
8.71
-19.379
-1.76%
-28.51%

What the Analysts think about VERA

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Vera Therapeutics stock.

VERA Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

VERA Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $VERA

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Vera Therapeutics stock?

Vera Therapeutics (VERA) has a market cap of $2.9B as of November 22, 2024.

What is the P/E ratio for Vera Therapeutics stock?

The price to earnings (P/E) ratio for Vera Therapeutics (VERA) stock is 0 as of November 22, 2024.

Does Vera Therapeutics stock pay dividends?

No, Vera Therapeutics (VERA) stock does not pay dividends to its shareholders as of November 22, 2024.

When is the next Vera Therapeutics dividend payment date?

Vera Therapeutics (VERA) stock does not pay dividends to its shareholders.

What is the beta indicator for Vera Therapeutics?

Vera Therapeutics (VERA) has a beta rating of 1.02. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.